title: Tests on protection against viral diseases.
abstract: Despite many attempts to find reliable in vitro criteria for the efficacy of Biological Response Modifiers--BRMs (immunomodulators, paramunity inducers) animal challenge models are still the only way to demonstrate the totality of interlocking defense mechanisms. Challenge models with mouse pathogenic viruses provide an excellent possibility to study protective effects of BRMs against acute or chronic forms of viral diseases. For comparative studies two completely different virus challenge models--Pseudorabies PR and Stomatitis Vesicularis VSV--were developed with adult and baby NMRI mice respectively. The potency of BRMs in preventing lethal disease reveals significant differences depending upon the sort of BRM, the route of application and the time of pretreatment. Defense mechanisms important for the control of Pseudorabies virus infection in adult NMRI mice were tested in vitro (ex vivo) and correlated well with the degree of protection in vivo. Comparison of BRM efficacy in selective viral challenge models combined with screening of a variety of antiviral defense functions in infected animals in vitro provide reliable methods in demonstrating the potency of BRMs against viral infections.
mesh_terms: D000208:Acute Disease; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D000831:Animals, Newborn; D001500:BCG Vaccine / Q000627:therapeutic use; D001688:Biological Products / Q000627:therapeutic use; D004195:Disease Models, Animal; D005260:Female; D011558:Herpesvirus 1, Suid / Q000302:isolation & purification / Q000502:physiology; D007372:Interferons / Q000097:blood; D007694:Killer Cells, Natural / Q000276:immunology; D007978:Levamisole / Q000627:therapeutic use; D051379:Mice; D011425:Propionibacterium acnes / Q000276:immunology; D011557:Pseudorabies / Q000628:therapy*; D013280:Stomatitis / Q000628:therapy; D014721:Vesicular stomatitis Indiana virus / Q000502:physiology; D014777:Virus Diseases / Q000628:therapy*
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D001688:Biological Products; C028621:PIND-AVI; C044867:PIND-ORF; D007978:Levamisole; D007372:Interferons